JP2024176004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024176004A5 JP2024176004A5 JP2023094181A JP2023094181A JP2024176004A5 JP 2024176004 A5 JP2024176004 A5 JP 2024176004A5 JP 2023094181 A JP2023094181 A JP 2023094181A JP 2023094181 A JP2023094181 A JP 2023094181A JP 2024176004 A5 JP2024176004 A5 JP 2024176004A5
- Authority
- JP
- Japan
- Prior art keywords
- triglyceride
- formula
- acid residue
- preventive
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 4
- 230000003449 preventive effect Effects 0.000 claims 4
- 210000002700 urine Anatomy 0.000 claims 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical group CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 claims 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims 1
- 241001306132 Aurantiochytrium Species 0.000 claims 1
- 241000195493 Cryptophyta Species 0.000 claims 1
- 206010017711 Gangrene Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 201000001431 Hyperuricemia Diseases 0.000 claims 1
- 206010024264 Lethargy Diseases 0.000 claims 1
- 235000021360 Myristic acid Nutrition 0.000 claims 1
- 206010029148 Nephrolithiasis Diseases 0.000 claims 1
- 241000233671 Schizochytrium Species 0.000 claims 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 201000003146 cystitis Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical group CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 201000006334 interstitial nephritis Diseases 0.000 claims 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical group [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 claims 1
- 230000027939 micturition Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 125000005471 saturated fatty acid group Chemical group 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023094181A JP2024176004A (ja) | 2023-06-07 | 2023-06-07 | 小胞体ストレス抑制剤、慢性腎臓病疾患予防改善剤および食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023094181A JP2024176004A (ja) | 2023-06-07 | 2023-06-07 | 小胞体ストレス抑制剤、慢性腎臓病疾患予防改善剤および食品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024176004A JP2024176004A (ja) | 2024-12-19 |
| JP2024176004A5 true JP2024176004A5 (cg-RX-API-DMAC10.html) | 2025-02-20 |
Family
ID=93894615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023094181A Pending JP2024176004A (ja) | 2023-06-07 | 2023-06-07 | 小胞体ストレス抑制剤、慢性腎臓病疾患予防改善剤および食品 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2024176004A (cg-RX-API-DMAC10.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
| US9532962B2 (en) * | 2007-11-02 | 2017-01-03 | Prometic Pharma Smt Limited | Medium-chain length fatty acids and glycerides as nephroprotection agents |
| JP6486072B2 (ja) * | 2014-11-04 | 2019-03-20 | 株式会社シー・アクト | 微生物由来の奇数脂肪酸又は高度不飽和脂肪酸含有するトリグリセリドの製造方法 |
| WO2022176677A1 (ja) * | 2021-02-19 | 2022-08-25 | 株式会社J-オイルミルズ | 筋肉増強用組成物及びその利用 |
-
2023
- 2023-06-07 JP JP2023094181A patent/JP2024176004A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Calder | Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake | |
| CN1338929A (zh) | 治疗精神性和神经性疾病的高纯乙基epa及其他epa衍生物 | |
| CN1108255A (zh) | 抑制经期前综合征/晚黄体期焦虑疾病的症状的方法 | |
| TW203625B (cg-RX-API-DMAC10.html) | ||
| Salvesen et al. | Idiopathic hypoparathyroidism | |
| JP2025509680A5 (cg-RX-API-DMAC10.html) | ||
| DK173547B1 (da) | Salicylsyreholdigt middel til lokalbehandling af hudsygdomme med skæl inden for den humane og den veterinære medicin | |
| JP2023061448A5 (cg-RX-API-DMAC10.html) | ||
| JP2008540534A (ja) | 放出調節薬学組成物 | |
| CN108703980A (zh) | 一种缓解痛经的组合物 | |
| Abbou et al. | Slipping rib syndrome | |
| CN106031722A (zh) | 治疗身体和神经系统失调或炎症引起的疾病的组合物及应用 | |
| JP2020536590A (ja) | 老化によって引き起こされる女性の障害を緩和するためのサプリメント | |
| CN1679679A (zh) | 一种中药组合物及其制备方法 | |
| JP2004331961A (ja) | 石けん | |
| LAYMON | Lichen sclerosus et atrophicus in childhood | |
| Walsh et al. | AZT myopathy and HIV-1 polymyositis: one disease or two? | |
| Carlström et al. | Treatment of Rheumatoid Arthritis with ATP | |
| JP4520623B2 (ja) | 低血圧症予防・治療剤 | |
| Monte et al. | Treating Swollen Glands and Skin Conditions: A Small Sheet of Medical Recipes (P. Mich. inv. 6803b) | |
| US20140314730A1 (en) | Composition and methods for relief of chemical sensitivity | |
| Bamber | Poikilodermatomyositis | |
| US20230063690A1 (en) | Compositions and methods for reducing pain and symptom(s) associated with seizures, slight strokes, and related illnesses and conditions | |
| Fedorova | KAMAKURA AND MUROMACHI PERIODS’MEDICAL VIEWS IN JAPANESE CULTURE | |
| Kim et al. | Gender-Related Variations in Canine Anterior Chamber Dimensions: Implications for Glaucoma Research |